Is it alarming to you that American companies would choose not to seek American approval for breakthroughs that they have?
Editor's note · Context
Burr questions the trend of companies bypassing U.S. drug approvals.
Share
More from Richard Burr
it is clearly apparent by listening to this debate, if Senator Sanders had been on the PEB board, the PEB board wouldn't be making a recommendation and the President wouldn't be behind it. But that is where we are, short of a breakthrough…
And the 12 that Roy has been in. But I have got to say that I never questioned whether Roy was going to be prepared, whether he was going to attend, whether he was going to absorb what he heard, and, more importantly, whether he was going…
Are you beginning to see the pattern as to why a plan is important? This has been a well-orchestrated event up to this point.
I will continue to ask you for a plan until we get one, and I will continue to be a roadblock for those who believe that we can blindly just appropriate emergency money.





